Vanceril and Neuropathy - peripheral - a phase IV clinical study of FDA data

Summary:

Neuropathy - peripheral is reported as a side effect among people who take Vanceril (beclomethasone dipropionate), especially for people who are female, 60+ old, also take Proventil,.

The phase IV clinical study analyzes which people have Neuropathy - peripheral when taking Vanceril. It is created by eHealthMe based on reports of 1,498 people who have side effects when taking Vanceril from the FDA, and is updated regularly.

What is Vanceril?

Vanceril has active ingredients of beclomethasone dipropionate. eHealthMe is studying from 1,502 Vanceril users. Check the latest studies of Vanceril.

What is Neuropathy - peripheral?

Neuropathy - peripheral (surface nerve damage) is found to be associated with 679 drugs and 1,007 conditions by eHealthMe. Check the latest studies of Neuropathy - peripheral.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

1,498 people reported to have side effects when taking Vanceril.
Among them, 11 people (0.73%) have Neuropathy - peripheral.

Could Vanceril cause Neuropathy - peripheral?

Among these 11 people:

What is the gender of people who have Neuropathy - peripheral when taking Vanceril? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Neuropathy - peripheral when taking Vanceril? *

What are other drugs people take besides Vanceril? *

What are other side effects people have besides Neuropathy - peripheral? *

Churg Strauss Syndrome (infection of small arteries and vein): 4 people, 36.36%
Hypoaesthesia (reduced sense of touch or sensation): 3 people, 27.27%
Weakness: 2 people, 18.18%
Acute Severe Asthma: 2 people, 18.18%
Weight Increased: 2 people, 18.18%
Tinnitus (a ringing in the ears): 2 people, 18.18%
Rash Erythematous (redness of the skin): 2 people, 18.18%
Difficulty In Walking: 1 person, 9.09%
Herpes Zoster: 1 person, 9.09%
Guillain-Barre Syndrome (the body's immune system attacks its peripheral nervous system): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Vanceril and have Neuropathy - peripheral?

- Check whether Neuropathy - peripheral is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vanceril:

Vanceril (1,502 reports)

Browse all side effects of Vanceril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neuropathy - peripheral:

Neuropathy - peripheral (679 drugs)

Browse all the conditions that are associated with Neuropathy - peripheral:

Neuropathy - peripheral (1,007 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on beclomethasone dipropionate (the active ingredients of Vanceril) and Vanceril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.